HRG reviewed 63 products in the health category, 31 items in the wellness sector and 37 products in the beauty aisle to see which ones stood out as Products to Watch.

GreensKeeper Asset Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

Jameela Jamil is weighing in on what makes her “uncomfortable” about Serena Williams’ admission that she is using a GLP-1 ...

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it ...

A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side ...

Philadelphia-based Thomas Jefferson University, owner of Jefferson Health, recorded an operating loss of $196 million (-1.2% operating margin) in fiscal 2025, down from an operating income of $1.3 ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic retinopathy (DR) and with a ...

Serena Williams sparked a heated debate after revealing she lost 31 pounds using a GLP-1 drug. While the tennis legend ...

Food brands and manufacturers can own the ingredient conversation to win consumer trust and loyalty, and it starts with ...

New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...